Legislation of the 119th Congress

The bill increases PBM and drug‑price transparency and expands options for small employers, potentially lowering drug costs and broadening benefits access, but it also imposes sizable compliance and privacy burdens, risks market disruptions and reduced state consumer protections, and contains policy constraints (including on abortion coverage) that may narrow options for vulnerable enrollees.

1. house
3. senate
5. president

This bill increases regulatory clarity, pediatric and transplant-focused initiatives, and transparency that can improve access and oversight, but it does so while raising federal costs, imposing new administrative burdens, and introducing risks that could delay pediatric data, weaken enforcement incentives, and shift incentives for drug developers.

1. house
3. senate
5. president

This package delivers sizable tax relief, defense/industrial and targeted domestic investments while tightening immigration and benefit rules and expanding fossil fuel development — producing near‑term financial and program gains for many Americans at the cost of higher federal spending, greater compliance burdens, and increased risks to climate, coverage, and immigrant access.

1. house
3. senate
5. president

1. house
3. senate
5. president

The bill expands and clarifies HSA coverage for preventive services for people with chronic conditions—reducing out-of-pocket costs and encouraging preventive care—while creating some legal ambiguity about non-listed services and imposing modest fiscal and regulatory constraints.

1. house
3. senate
5. president

The resolution creates a clearer, enforceable multi‑year budget framework that can improve transparency, planning, and fiscal discipline, but it concentrates significant allocation authority, may constrain spending flexibility and program benefits, and does not itself provide funding.

1. senate
3. house

This resolution promotes better palliative and hospice practices and patient-centered end-of-life care through training and awareness, but because it is nonbinding and provides no funding, its practical impact on access and provider burden will be limited without follow-up resources or mandates.

1. senate

The resolution raises federal visibility of violence against transgender people and strengthens the factual basis for supportive services, improving potential protections and resources, but it also risks political and legal backlash and cost objections that could delay or complicate implementation.

1. senate

The resolution raises awareness and federal recognition of family caregivers—potentially mobilizing advocacy and informing policy—but is symbolic and does not provide funding or direct relief, so it increases visibility without delivering material support.

1. senate

The resolution increases awareness and supports federal prevention efforts to identify and prevent high LDL‑C and lipoprotein(a)‑related heart risk—potentially improving detection and care—but without funding or coverage changes it may lead to more testing and cost burdens and heightened expectations that outpace available access, especially in underserved communities.

1. senate

The resolution encourages expanded, data-driven community maternal and infant health efforts to reduce infant mortality and racial disparities, but it could increase public spending and create unfunded expectations or insufficiently tailored responses if follow-up funding and implementation are not provided.

1. senate

The resolution increases fiscal enforcement and public transparency about deficits but does so by triggering broad, automatic cuts that risk large reductions in health coverage, Medicare benefits, and social‑safety‑net supports for vulnerable Americans.

1. senate

The bill increases U.S. investment and leadership to strengthen global health systems—reducing pandemic risk and improving care for low‑income populations abroad—but it requires higher U.S. spending and creates budget tradeoffs while its long‑term effectiveness depends on political and economic conditions in recipient countries.

1. senate

The bill preserves no-cost access to evidence-based preventive services and strengthens transparency, improving preventive care for many Americans, but raises fiscal pressures and risks slower or politicized updates to recommendations if funding or governance changes impede timely, independent reviews.

1. senate

The resolution strengthens health-sector and community protections and resilience against climate-related disasters—especially for people with disabilities and underserved areas—while creating costs and implementation challenges that could fall on taxpayers, small providers, employers, and slower-moving governments.

1. senate

The bill strengthens transparency, stakeholder input, and procedural predictability in HHS rulemaking—helping protect Americans from arbitrary rules—but at the cost of slower rule issuance and modestly higher taxpayer-funded administrative costs.

1. senate

The resolution recognizes and documents the sizeable and growing osteopathic physician workforce and its rural training role—highlighting potential benefits for access—while remaining a findings-only measure that provides no funding or policy changes to realize those benefits.

1. senate

The resolution could improve maternal and infant outcomes and reduce costs by expanding and legitimizing midwifery—especially for Black birthing people and underserved communities—but benefits are likely to be uneven, may be delayed by state regulation, and will require funding and care coordination to avoid shifting risks or imposing new public costs.

1. senate

The resolution aims to impose multi‑year fiscal discipline, greater transparency, and targeted reserves to speed certain reforms, but in doing so it tightens rules and concentrates discretion in ways that can increase gridlock, reduce flexibility for emergencies, and raise the risk of future cuts or costs shifted onto taxpayers and beneficiaries.

1. senate
3. house

The bill expands Medicare coverage and clarifies billing for implanted middle ear devices—improving access and lowering out-of-pocket costs for eligible beneficiaries—while increasing program spending and leaving a risk that CMS implementation rules could limit access or shift costs to some patients.

1. senate
3. house
5. president

The bill prioritizes reducing federal funding and clarifying rules against taxpayer-subsidized gender transition procedures—saving federal outlays and creating administrative certainty—at the cost of restricting access to care for transgender people and imposing financial and administrative burdens on patients, employers, insurers, and health systems.

1. senate
3. house
5. president

The bill tightens oversight to better protect enrollees and detect fraud but does so at the cost of higher compliance and administrative burdens that could reduce broker availability, strain small producers' finances, and raise costs for taxpayers or premiums.

1. senate
3. house
5. president

The bill expands and clarifies donor reimbursement eligibility and reporting—improving equitable access and transparency for donors—at the cost of higher potential federal spending and added administrative burdens, with no guarantee Congress will fully fund identified shortfalls.

1. senate
3. house
5. president

The bill extends long-sought dental, hearing, and vision benefits to Medicare beneficiaries—improving access and reducing some out-of-pocket costs—while relying on conservative payment rates, coverage limits, competitive procurement, and phased premium adjustments that could limit provider participation, beneficiary choice, and shift costs into future years.

1. senate
3. house
5. president

The bill increases Medicaid pharmacy pricing transparency and aims to direct more funds to patient care by curbing PBM spread‑pricing and requiring detailed reporting, but it imposes substantial compliance costs, disclosure risks, and reduces some procedural rulemaking protections that could strain small pharmacies, states, and plans.

1. senate
3. house
5. president

This bill boosts transparency, expands public‑health preparedness and targeted health program funding, and strengthens beneficiary protections—while imposing substantial new federal spending, widespread reporting and compliance costs, privacy and procedural tradeoffs, and implementation uncertainty that could shift costs to states, providers, employers, and patients.

1. senate
3. house
5. president

The bill makes third‑party copay assistance count toward patient cost‑sharing — reducing immediate out‑of‑pocket drug costs and preserving HSA status for HDHP enrollees — at the potential cost of weakening long‑term price pressure on insurers/manufacturers and prompting plan responses (more utilization management or formulary changes) that could delay access and raise administrative burden.

1. senate
3. house
5. president

The bill expands federal employee health benefits to cover a wide range of fertility services—improving access and lowering out-of-pocket costs for employees while increasing program costs and raising questions about future coverage scope and moral objections.

1. senate
3. house
5. president

The bill preserves HSA eligibility and tax advantages while promoting telehealth access, but it may modestly increase premiums, complicate plan administration, and enable benefit-design choices that weaken cost-sharing incentives.

1. senate
3. house
5. president